<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04852432</url>
  </required_header>
  <id_info>
    <org_study_id>H2103-095-1205</org_study_id>
    <nct_id>NCT04852432</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients</brief_title>
  <official_title>Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators evaluate the efficacy and safety of routine administration of oxygen during&#xD;
      moderate or deep sedation in pediatric patients. In addition, in terms of efficacy and&#xD;
      safety, oxygen administration via nasal prong and high flow nasal cannula will be compared.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 5, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Desaturation (≤95%)</measure>
    <time_frame>through study completion, average 30 minutes</time_frame>
    <description>Occurrence of desaturation (pulse oximeter ≤95%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Desaturation (≤90%)</measure>
    <time_frame>through study completion, average 30 minutes</time_frame>
    <description>Occurrence of desaturation (pulse oximeter ≤90%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO2 value</measure>
    <time_frame>through study completion, average 30 minutes</time_frame>
    <description>percutaneous CO2 (maximum, minimum, mean values)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum saturation during sedation</measure>
    <time_frame>through study completion, average 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>through study completion, average 30 minutes</time_frame>
    <description>Any complications during sedation</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">258</enrollment>
  <condition>Pediatric Sedation</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Nasal prong is applied, but sedation is performed without oxygen administration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low flow group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen administration by nasal cannula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen is administered at a rate of 2L/kg/min using an Optiflow device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>high flow nasal cannula</intervention_name>
    <description>The heated air is administered at a rate of 2L/kg/min using an Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand). Inhalation oxygen concentration starts with 50%.</description>
    <arm_group_label>High flow group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nasal prong</intervention_name>
    <description>Oxygen is administered via nasal prong</description>
    <arm_group_label>Low flow group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children under the age of 18 who undergo moderate-deep sedation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Respiratory failure patients&#xD;
&#xD;
          -  Increased intracranial pressure&#xD;
&#xD;
          -  Recent massive nasal bleeding&#xD;
&#xD;
          -  History of airway surgery&#xD;
&#xD;
          -  Complete nasal obstruction&#xD;
&#xD;
          -  Pulmonary hypertension&#xD;
&#xD;
          -  Skull base fracture&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Tae Kim, MD, PhD</last_name>
    <phone>02-2072-3661</phone>
    <phone_ext>82</phone_ext>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 15, 2021</study_first_submitted>
  <study_first_submitted_qc>April 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

